Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-15

Clinical Trial Update: Efficacy of AMALS in Treating Language Impairment in Children [Phase 2]

View source ↗

Summary

Phase 2 trial results assess the efficacy of AMALS for language impairment in children, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMALS

Snippet

Sponsor: Lamar University | Conditions: Language Disorder | Phase 2 | Status: COMPLETED | Results posted: 2012-05-15